For Investors
Where Systems Thinking Meets Investment Intelligence
Agricultural biologicals are one of the most promising, and most technically complex, sectors in AgTech. The upside is real. So is the risk of backing biology that sounds better in a pitch deck than it performs in a field.
Quadros Bio Inc. provides independent, science-based risk intelligence so you can deploy capital with confidence.
17+
years of academic, lab, and field experience across three continents
38+
peer-reviewed publications and over 2,200 academic citations
7
readiness layers in the QBIView assessment framework
How We Help
The Problem We Solve
Founders are more sophisticated than ever. AI has made pitch decks more polished and data-rich. But lab science is not commercial agriculture, and the gap between a promising bacterial strain and a product that actually works in farmers' fields is where most biologicals investments lose value.
01
Pre-Investment
Technical Validation
QBIView™ Technology Assessment
Most biological claims don't survive close scrutiny. QBIView™ is Quadros Bio Inc.'s proprietary due diligence framework: a structured, evidence-based assessment that tells you what the pitch deck doesn't.
Every assessment applies our 7 Readiness Layers framework. Each layer is scored independently. Weaknesses don't hide behind strengths.
The 7 Readiness Layers
- 01Science Foundation
- 02Biological Product Integrity
- 03Regulatory Readiness
- 04Commercial Viability
- 05Organizational & IP Strength
- 06R&D Culture
- 07Capital & Governance Integrity
Deliverables include:
- →Structured technical interview with founders and technical team
- →Independent patent landscape search across CIPO, USPTO, EPO, INPI, and WIPO
- →Regulatory pathway assessment with realistic timelines
- →Competitive benchmarking against products in similar categories
- →Probability scenarios for the three most likely commercial outcomes
- →Final QBI Verdict: Go / Conditional / No-Go
- →Specific deal-term restructuring recommendations
The report closes with a QBI Verdict (Go / Conditional / No-Go) and specific deal-term restructuring recommendations. You don't just learn what the risks are. You learn how to structure around them.
02
Ongoing Portfolio
Intelligence
QBI Partnership Retainer
Biological markets move faster than most investors track. Regulatory decisions, emerging strain data, competitive approvals, and field trial failures reshape the landscape continuously, and most of it never surfaces in pitch decks or press releases.
The QBI Partnership retainer keeps you informed on the science that affects what you already own.
What we monitor
- →Regulatory monitoring at PMRA, CFIA, and EPA
- →Competitive product approvals and IP filing tracking
- →Machine-learning pattern-matching of emerging biological technologies against historical commercialization data
- →Early signal detection of portfolio company risk before it becomes a board-level problem
For funds with multiple biologicals positions, this is the layer of scientific judgment that turns reactive portfolio management into proactive risk intelligence.
03
Brazilian Research
Network
Deal Origination
Brazil is the world's largest commercial market for agricultural biologicals. The country's regulatory framework, field trial infrastructure, and research output, anchored by Embrapa and leading federal universities, is producing innovations that most North American investors encounter only after valuations have already climbed.
Quadros Bio Inc. holds direct research relationships with the Embrapa network and Brazilian academic institutions built over 17+ years of primary field research across South American soil systems. We surface technologies at the stage where scientific validation is possible and deal terms are still favourable, and we assess them using the same QBIView™ framework before you take a meeting.
"If you're building a biologicals portfolio and not watching Brazil, you're watching the wrong market."
Dr. Patricia Dörr de Quadros, Founder & CEO
Confidential by default. Not sold. Not published. Not shared without permission.
Ready to de-risk your next investment?
Let's talk about your next biologicals decision.
Schedule a 20-minute consultation to discuss how Quadros Bio Inc. can help you separate credible biology from compelling pitch decks.